Effect of buspirone on thermal sensory and pain thresholds in human volunteers.

Goran Pavlaković, Julija Tigges, Thomas A Crozier
{"title":"Effect of buspirone on thermal sensory and pain thresholds in human volunteers.","authors":"Goran Pavlaković,&nbsp;Julija Tigges,&nbsp;Thomas A Crozier","doi":"10.1186/1472-6904-9-12","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Buspirone is a partial 5-HT1A receptor agonist. Animal studies have shown that modulation of serotoninergic transmission at the 5-HT1A receptor can induce analgesia in acute pain models. However, no studies have been published so far on the effects of serotonin receptor agonists on pain perception in humans.</p><p><strong>Methods: </strong>The effects of buspirone (30 mg p.o.) on thermal sensory and pain thresholds were investigated in twelve female volunteers (26 +/- 2 yrs) in a prospective, randomized, double-blind, double-dummy, placebo-controlled study with morphine (10 mg i.v.) as positive control.</p><p><strong>Results: </strong>Morphine significantly increased the heat pain detection threshold (DeltaT: placebo 1.0 degrees C and 1.3 degrees C, p < 0.05) at 60 minutes. Buspirone caused mild sedation in six participants at 60 minutes, but was without effect on any of the measured parameters.</p><p><strong>Conclusion: </strong>Buspirone in the maximal recommended dose was without significant effect on thermal pain. However, as it is only a partial agonist at the 5-HT1A receptor and also acts on other receptor types, the negative results of the present study do not rule out a possible analgesic effect of more specific 5-HT1A receptor agonists.</p>","PeriodicalId":9196,"journal":{"name":"BMC Clinical Pharmacology","volume":"9 ","pages":"12"},"PeriodicalIF":0.0000,"publicationDate":"2009-05-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1186/1472-6904-9-12","citationCount":"26","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"BMC Clinical Pharmacology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1186/1472-6904-9-12","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 26

Abstract

Background: Buspirone is a partial 5-HT1A receptor agonist. Animal studies have shown that modulation of serotoninergic transmission at the 5-HT1A receptor can induce analgesia in acute pain models. However, no studies have been published so far on the effects of serotonin receptor agonists on pain perception in humans.

Methods: The effects of buspirone (30 mg p.o.) on thermal sensory and pain thresholds were investigated in twelve female volunteers (26 +/- 2 yrs) in a prospective, randomized, double-blind, double-dummy, placebo-controlled study with morphine (10 mg i.v.) as positive control.

Results: Morphine significantly increased the heat pain detection threshold (DeltaT: placebo 1.0 degrees C and 1.3 degrees C, p < 0.05) at 60 minutes. Buspirone caused mild sedation in six participants at 60 minutes, but was without effect on any of the measured parameters.

Conclusion: Buspirone in the maximal recommended dose was without significant effect on thermal pain. However, as it is only a partial agonist at the 5-HT1A receptor and also acts on other receptor types, the negative results of the present study do not rule out a possible analgesic effect of more specific 5-HT1A receptor agonists.

Abstract Image

Abstract Image

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
丁螺环酮对人类志愿者热感觉和痛阈的影响。
背景:丁螺环酮是部分5-HT1A受体激动剂。动物研究表明,调节5-HT1A受体的5-羟色胺能传递可以诱导急性疼痛模型的镇痛。然而,到目前为止,还没有关于血清素受体激动剂对人类疼痛感知的影响的研究发表。方法:采用前瞻性、随机、双盲、双假、安慰剂对照研究,观察丁螺环酮(30 mg p.o)对12名女性志愿者(26±2岁)热感觉和疼痛阈值的影响,吗啡(10 mg静脉注射)为阳性对照。结果:吗啡在60分钟显著提高热痛检测阈值(DeltaT:安慰剂1.0℃和1.3℃,p < 0.05)。丁螺环酮在60分钟内对6名参与者产生轻度镇静作用,但对任何测量参数都没有影响。结论:丁螺环酮在最大推荐剂量下对热痛无显著影响。然而,由于它只是5-HT1A受体的部分激动剂,并且还作用于其他受体类型,因此本研究的阴性结果并不排除更特异性的5-HT1A受体激动剂可能具有镇痛作用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Statin therapy in critical illness: an international survey of intensive care physicians' opinions, attitudes and practice. Correction: Adverse drug reactions to antiretroviral therapy (ARVs): incidence, type and risk factors in Nigeria Data for drugs available through low-cost prescription drug programs are available through pharmacy benefit manager and claims data. Population prevalence of high dose paracetamol in dispensed paracetamol/opioid prescription combinations: an observational study. Adherence to medication for the treatment of psychosis: rates and risk factors in an Ethiopian population.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1